Form 483

Park Avenue Compounding Form 483, 2019-08-28

FDA issued a Form 483 to Park Avenue Compounding on 2019-08-28 with 8 public-safe observations.

483· Form 483 issuedHuman Drugs8 observations

Park Avenue Compounding · Saint Louis, United States · Issued August 28, 2019

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Aug 2019
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Mindy M Chou

28 Aug 2019
21 CFR 211.160(b)(1)

Sampling and testing procedures described

Cited by Mindy M Chou

28 Aug 2019
21 CFR 211.165(a)

Testing and release for distribution

Cited by Mindy M Chou

28 Aug 2019
21 CFR 211.165(d)

Acceptance criteria for sampling & testing

Cited by Mindy M Chou

28 Aug 2019
21 CFR 211.25(a)

Training--operations, GMPs, written procedures

Cited by Mindy M Chou

Inspected site

PAPark Avenue CompoundingSaint Louis, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.28(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x
21 CFR 211.46(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere